Rein DB - Search Results

1

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.

Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, Patel N, Ward JW, Weinbaum CM. Rein DB, et al. Ann Intern Med. 2012 Feb 21;156(4):263-70. doi: 10.7326/0003-4819-156-4-201202210-00378. Epub 2011 Nov 4. Ann Intern Med. 2012. PMID: 22056542 Free PMC article.

2

Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.

Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL. Rein DB, et al. Pediatrics. 2007 Jan;119(1):e12-21. doi: 10.1542/peds.2006-1573. Pediatrics. 2007. PMID: 17200237

3

Cost-effectiveness of vitamin therapy for age-related macular degeneration.

Rein DB, Saaddine JB, Wittenborn JS, Wirth KE, Hoerger TJ, Narayan KM, Clemons T, Sorensen SW. Rein DB, et al. Ophthalmology. 2007 Jul;114(7):1319-26. doi: 10.1016/j.ophtha.2006.10.041. Epub 2007 Feb 22. Ophthalmology. 2007. PMID: 17320962 Clinical Trial.

4

Technical appendix: cost-effectiveness of vitamin therapy for age-related macular degeneration.

Rein DB, Saaddine JB, Wittenborn JS, Wirth K, Hoerger TJ, Narayan KM, Clemons T, Sorensen SW. Rein DB, et al. Ophthalmology. 2007 Jul;114(7):e13-20. doi: 10.1016/j.ophtha.2006.10.064. Epub 2007 Apr 26. Ophthalmology. 2007. PMID: 17462738 No abstract available.

5

The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.

Rein DB, Weinbaum CM. Rein DB, et al. Vaccine. 2008 Oct 3;26(42):5331-3. doi: 10.1016/j.vaccine.2008.07.089. Epub 2008 Aug 14. Vaccine. 2008. PMID: 18706957

6

The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.

Rein DB, Wittenborn JS, Lee PP, Wirth KE, Sorensen SW, Hoerger TJ, Saaddine JB. Rein DB, et al. Ophthalmology. 2009 May;116(5):823-32. doi: 10.1016/j.ophtha.2008.12.056. Epub 2009 Mar 14. Ophthalmology. 2009. PMID: 19285730

7

Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.

Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J; Vision Health Cost-Effectiveness Study Group. Rein DB, et al. Arch Ophthalmol. 2009 Apr;127(4):533-40. doi: 10.1001/archophthalmol.2009.58. Arch Ophthalmol. 2009. PMID: 19365036

8

Community-based hepatitis B screening programs in the United States in 2008.

Rein DB, Lesesne SB, Leese PJ, Weinbaum CM. Rein DB, et al. J Viral Hepat. 2010 Jan;17(1):28-33. doi: 10.1111/j.1365-2893.2009.01165.x. Epub 2009 Aug 6. J Viral Hepat. 2010. PMID: 19674286

9

Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008.

Rein DB, Lesesne SB, O'Fallon A, Weinbaum CM. Rein DB, et al. Hepatology. 2010 Feb;51(2):431-4. doi: 10.1002/hep.23353. Hepatology. 2010. PMID: 19902482

10

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.

Rein DB, Wittenborn JS, Weinbaum CM, Sabin M, Smith BD, Lesesne SB. Rein DB, et al. Dig Liver Dis. 2011 Jan;43(1):66-72. doi: 10.1016/j.dld.2010.05.006. Epub 2010 Jun 17. Dig Liver Dis. 2011. PMID: 20739252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters